4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-003534
Chief Executive Officer sold 31,805 shares at an average $1.72 ($54,791)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2023-01-11 | Sale | −13,042 | $1.75 | $22,782 | 17,298 | D |
| Rawcliffe Adrian Chief Executive Officer | 2023-01-12 | Sale | −18,763 | $1.71 | $32,010 | 24,882 | D |
| Open-market sales · 31,805 sh · avg $1.72 · $54,791 | |||||||
Loading xslF345X03/tm231655-5_4seq1.xml…